Aurobindo Pharma Ltd. (AUROPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 164981, "name": "Aurobindo Pharma", "stock_name": "Aurobindo Pharma", "full_name": "Aurobindo Pharma Ltd.", "name_url": "stocks-analysis/aurobindo-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,528.35", "chg": -7.15, "chgp": "-0.47%", "dir": -1, "prev_price": "1,535.50", "mcapval": "89,850.00 Cr", "mcap": "Mid Cap", "scripcode": 524804, "symbol": "AUROPHARMA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE406A01037", "curr_date": "Jun 24, 03:31 PM", "curr_time": "15:38 PM", "last_traded_at": "Jun 24, 03:31 PM IST", "bse_nse_vol": "10.13 lacs", "exc_status": "Active", "traded_date": "Jun 24, 2026", "traded_date_str": "2026 06 24", "score": "", "scoreText": "", "Live": 0, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aurobindo-pharma-164981-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1550.1", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-new-52-week-high-at-rs15501-4069967", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AurobindoPharma_priceRelatedfactors_4069967.png", "date": "2026-06-24 09:40:05", "description": "With a decisive breakout to Rs 1550.1 on 24 Jun 2026, Aurobindo Pharma Ltd. has reached a fresh 52-week high, extending its impressive 39.46% gain over the past year against a Sensex decline of 6.85%. This milestone reflects a confluence of strong technical momentum and sustained price strength across multiple timeframes." }, { "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-amid-mixed-market-signals-4067623", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AurobindoPharma_oi_spurts_by_underlying_4067623.png", "date": "2026-06-22 15:00:07", "description": "Aurobindo Pharma Ltd. has witnessed a notable 12.02% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a slight dip in the stock price, the pharmaceutical mid-cap’s derivatives market reveals intriguing directional bets and volume patterns that merit close analysis." }, { "title": "Aurobindo Pharma Gains 1.74%: 4 Key Factors Driving This Week’s Mixed Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-gains-174-4-key-factors-driving-this-weeks-mixed-momentum-4066323", "imagepath": "", "date": "2026-06-21 15:00:05", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>15 Jun:</strong> Intraday low amid price pressure; stock falls 4.43%</p>\n <p><strong>15 Jun:</strong> Sharp open interest surge in derivatives by 12.87%</p>\n <p><strong>16 Jun:</strong> Technical momentum shifts to mildly bullish despite volatility</p>\n <p><strong>19 Jun:</strong> Technical momentum strengthens to bullish; stock gains 1.47%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,472.25</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div cla..." }, { "title": "Aurobindo Pharma Ltd. is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/aurobindo-pharma-ltd-is-rated-hold-by-marketsmojo-4063090", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AurobindoPharma_mojoScore_4063090.png", "date": "2026-06-19 10:10:57", "description": "Aurobindo Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 19 June 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook." }, { "title": "Aurobindo Pharma Ltd. Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Market Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-technical-momentum-shifts-signal-bullish-outlook-amid-mixed-market-returns-4062544", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AurobindoPharma_technicaldot_4062544.png", "date": "2026-06-19 08:00:16", "description": "Aurobindo Pharma Ltd. has experienced a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend, despite a recent downgrade in its Mojo Grade from Buy to Hold. The stock’s price action, supported by key technical indicators such as MACD, moving averages, and Bollinger Bands, suggests an improving outlook amid mixed signals from volume-based metrics and Dow Theory assessments." }, { "title": "Aurobindo Pharma Ltd. Technical Momentum Shifts Amid Market Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-technical-momentum-shifts-amid-market-volatility-4054786", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AurobindoPharma_technicaldot_4054786.png", "date": "2026-06-16 08:00:30", "description": "Aurobindo Pharma Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent decline of 4.43% in its share price to ₹1,407.00 on 16 Jun 2026, the stock’s longer-term indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other technical parameters." }, { "title": "Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-sees-sharp-open-interest-surge-amid-mixed-market-signals-4054567", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AurobindoPharma_oi_spurts_by_underlying_4054567.png", "date": "2026-06-15 15:00:07", "description": "Aurobindo Pharma Ltd. has witnessed a notable 12.87% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with volume patterns and price movements, offers critical insights into evolving market positioning and potential directional bets on the mid-cap pharmaceutical giant." }, { "title": "Aurobindo Pharma Ltd. Hits Intraday Low Amid Price Pressure on 15 Jun 2026", "link": "https://www.marketsmojo.com/news/stocks-in-action/aurobindo-pharma-ltd-hits-intraday-low-amid-price-pressure-on-15-jun-2026-4054539", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AurobindoPharma_priceRelatedfactors_4054539.png", "date": "2026-06-15 14:16:09", "description": "Aurobindo Pharma Ltd. experienced a notable decline in intraday trading on 15 Jun 2026, with the stock touching a low of Rs 1,397.5, reflecting a 5.08% drop. This downturn came despite broader market gains, as the Sensex advanced by 1.14%, highlighting sector-specific pressures and a reversal in the stock’s recent upward trend." }, { "title": "Aurobindo Pharma Ltd. is Rated Hold by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/aurobindo-pharma-ltd-is-rated-hold-by-marketsmojo-4037207", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AurobindoPharma_mojoScore_4037207.png", "date": "2026-06-08 10:10:40", "description": "Aurobindo Pharma Ltd. is rated Hold by MarketsMOJO, with this rating last updated on 25 May 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook." } ], "total": 824, "sid": "164981", "stock_news_url": "https://www.marketsmojo.com/news/aurobindo-pharma-164981" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "22-Jun-2026", "details": "Submission of Press Release that is being issued by the Company.", "source": "BSE" }, { "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.", "datetime": "19-Jun-2026", "details": "Intimation of receipt of necessary approvals from US Federal Trade Commission (FTC) for the acquisition of Lannett business.", "source": "BSE" }, { "caption": "Completion Of US FDA Pre-Approval Inspection (PAI) At Eugia Steriles Private Limited A 100% Stepdown Subsidiary Of The Company", "datetime": "19-Jun-2026", "details": "Intimation of completion of US FDA Pre-Approval Inspection (PAI) at Eugia Steriles Private Limited a 100% stepdown subsidiary of the Company.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Aurobindo Pharma Ltd. has declared <strong>400%</strong> dividend, ex-date: 08 Aug 25", "dt": "2025-08-08", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Aurobindo Pharma Ltd. has announced <strong>1:5</strong> stock split, ex-date: 10 Feb 11", "dt": "2011-02-10", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Aurobindo Pharma Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 20 Jul 15", "dt": "2015-07-20", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

15 Jun: Intraday low amid price pressure; stock falls 4.43%

15 Jun: Sharp open interest surge in derivatives by 12.87%

16 Jun: Technical momentum shifts to mildly bullish despite volatility

19 Jun: Technical momentum strengthens to bullish; stock gains 1.47%

Week Open

Rs.1,472.25

Week Close

Read full news article

Aurobindo Pharma Ltd. is Rated Hold by MarketsMOJO

2026-06-19 10:10:57

Aurobindo Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 19 June 2026, providing investors with the most up-to-date perspective on the company’s performance and outlook.

Read full news article

Aurobindo Pharma Ltd. Technical Momentum Shifts Signal Bullish Outlook Amid Mixed Market Returns

2026-06-19 08:00:16

Aurobindo Pharma Ltd. has experienced a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend, despite a recent downgrade in its Mojo Grade from Buy to Hold. The stock’s price action, supported by key technical indicators such as MACD, moving averages, and Bollinger Bands, suggests an improving outlook amid mixed signals from volume-based metrics and Dow Theory assessments.

Read full news article

Aurobindo Pharma Ltd. Technical Momentum Shifts Amid Market Volatility

2026-06-16 08:00:30

Aurobindo Pharma Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a recent decline of 4.43% in its share price to ₹1,407.00 on 16 Jun 2026, the stock’s longer-term indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other technical parameters.

Read full news article

Aurobindo Pharma Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-06-15 15:00:07

Aurobindo Pharma Ltd. has witnessed a notable 12.87% increase in open interest in its derivatives segment, signalling heightened market activity despite the stock’s recent underperformance. This surge in open interest, coupled with volume patterns and price movements, offers critical insights into evolving market positioning and potential directional bets on the mid-cap pharmaceutical giant.

Read full news article

Aurobindo Pharma Ltd. Hits Intraday Low Amid Price Pressure on 15 Jun 2026

2026-06-15 14:16:09

Aurobindo Pharma Ltd. experienced a notable decline in intraday trading on 15 Jun 2026, with the stock touching a low of Rs 1,397.5, reflecting a 5.08% drop. This downturn came despite broader market gains, as the Sensex advanced by 1.14%, highlighting sector-specific pressures and a reversal in the stock’s recent upward trend.

Read full news article

Aurobindo Pharma Ltd. is Rated Hold by MarketsMOJO

2026-06-08 10:10:40

Aurobindo Pharma Ltd. is rated Hold by MarketsMOJO, with this rating last updated on 25 May 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article